M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Other Current Liabilities Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Other Current Liabilities
$372.8k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Other Current Liabilities
$13m
CAGR 3-Years
-11%
CAGR 5-Years
4%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Other Current Liabilities
CHf86.5m
CAGR 3-Years
561%
CAGR 5-Years
86%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Other Current Liabilities
$10.1m
CAGR 3-Years
26%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Other Current Liabilities
CHf585k
CAGR 3-Years
-75%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Other Current Liabilities
CHf3.9m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Other Current Liabilities?
Other Current Liabilities
372.8k USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Other Current Liabilities amounts to 372.8k USD.

What is MoonLake Immunotherapeutics's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 1Y
211%

Over the last year, the Other Current Liabilities growth was 211%.

Back to Top